Diabetes

Top Story

New guideline emphasizes simpler diabetes regimens, looser glycemic targets for older adults

March 23, 2019

Novo Nordisk files new drug applications for oral, injectable semaglutide

March 20, 2019
Novo Nordisk on Wednesday submitted two new drug applications for oral semaglutide, seeking approval for the drug as an adjunct to diet and exercise in adults with type…
Meeting NewsPerspective

CV benefits of diabetes drug dapagliflozin extend to patients with reduced ejection fraction

March 18, 2019
NEW ORLEANS — Treatment with the SGLT2 inhibitor dapagliflozin reduced HF hospitalizations in patients with a broad range of left ventricular ejection fraction and…
Meeting NewsPerspective

Prescription fish oil cuts total ischemic events in new REDUCE-IT analysis

March 18, 2019
NEW ORLEANS — Icosapent ethyl, a pharmaceutical-grade omega-3 fatty acid, was in the spotlight again at the American College of Cardiology Scientific Session, with…
More Headlines »
CME ABIM MOC

PCSK9 Inhibitors in Patients With Diabetes: A Closer Look at CV Risk Reduction

This activity is supported by an educational grant from Amgen.

There is an association between atherosclerotic cardiovascular disease and low-density lipoprotein cholesterol as well…
More »
Video
Meeting News

In type 2 diabetes, consider disease burden when managing blood pressure

May 18, 2018
More »
Video
Meeting News

VIDEO: Cardiologists debate CV risk predictors in patients with diabetes

July 16, 2017
More »